Researchers are seeking to update staging guidelines for cutaneous squamous cell carcinoma.
Immunotherapy a Game Changer for Case of Advanced Cutaneous Squamous Cell Carcinoma
A patient with advanced cutaneous squamous cell carcinoma achieved a near complete response from immunotherapy.
Study Identifies Prognostic Subgroups in Cutaneous Squamous Cell Carcinoma
Researchers are attempting to update and expand upon traditional tumor classification systems using recursive partitioning analysis, a modeling technique focused on predicting survival in patients with high-risk cutaneous squamous cell carcinoma.
Could Immunotherapy Help Cure Cutaneous Squamous Cell Carcinoma?
The phase 3 KEYNOTE-630 trial has begun enrolling patients with high-risk, locally advanced cutaneous squamous cell carcinoma (cSCC) to evaluate the curative potential of PD-1 inhibitor pembrolizumab.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy